Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for IDEAYA Biosciences (IDYA) over the last 5 years, with Dec 2024 value amounting to -$3.36.

  • IDEAYA Biosciences' EPS (Weighted Average and Diluted) rose 321.67% to $1.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.50, marking a year-over-year increase of 35.62%. This contributed to the annual value of -$3.36 for FY2024, which is 71.43% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported EPS (Weighted Average and Diluted) of -$3.36 as of FY2024, which was down 71.43% from -$1.96 recorded in FY2023.
  • IDEAYA Biosciences' EPS (Weighted Average and Diluted)'s 5-year high stood at -$1.40 during FY2020, with a 5-year trough of -$3.36 in FY2024.
  • For the 3-year period, IDEAYA Biosciences' EPS (Weighted Average and Diluted) averaged around -$2.25, with its median value being -$1.96 (2023).
  • Data for IDEAYA Biosciences' EPS (Weighted Average and Diluted) shows a maximum YoY slumped of 71.43% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' EPS (Weighted Average and Diluted) stood at -$1.40 in 2020, then declined by 0.71% to -$1.41 in 2021, then decreased by 0.71% to -$1.42 in 2022, then plummeted by 38.03% to -$1.96 in 2023, then slumped by 71.43% to -$3.36 in 2024.